asian games

stakezoncasino| Hua 'an Synthetic Biology Index: Down 2.24%, the bioeconomy trillion-dollar track is on track

2024-04-30 发布 0条评论

Newsletter summary

Developments in the field of synthetic biology this week: Hua'an synthetic Biology Index fell 2.Stakezoncasino.24%, Huaheng Biology has an annual output of 50, 000 tons of PDO project to achieve high-quality continuous production, Shenzhen state-owned investment of 1.5 billion in the synthetic biological industry, state creature to achieve a breakthrough in spider silk protein synthesis technology.

Text of news flash

Huaan Securities released the synthetic Biology Weekly to show the development trend of the synthetic biology industry and the establishment of Huaan Securities Chemical team.StakezoncasinoThe synthetic Biology Weekly provides domestic and foreign synthetic biology enterprises for investors.StakezoncasinoThe latest developments. This weekly report covers the primary market and the secondary market, is a summary of information in the field of synthetic biology, and has important reference value for investors.

stakezoncasino| Hua 'an Synthetic Biology Index: Down 2.24%, the bioeconomy trillion-dollar track is on track

Active research in the field of synthetic biology and broad prospects for industrial development with the advancement of the global biotechnology revolution, synthetic biology is gradually integrated into all fields of economic and social development. to provide new solutions to solve major problems such as life and health, climate change and so on. The 14th five-year Plan for Bio-economic Development of the National Development and Reform Commission indicates the rise of the trillions of track of bio-economy.

Huaan synthetic Biology Index fell this week, but outperformed Shanghai Composite Index and gem Index. According to data from Huaan Securities (600909) Research Institute, Huaan synthetic Biology Index is down 2% this week.Stakezoncasino.24% to 853.63 points. Despite the decline, the Hua'an synthetic Biology Index still outperformed the Shanghai Composite Index and the gem Index, outperforming the Shanghai Composite Index by 10.04 percentage points and the gem Index by 6.94 percentage points.

The 2024 synthetic Biology Conference and the Industrial Expo were held in Hubei and Nanjing. The 2024 synthetic Biology Conference was hosted by the School of Life Sciences of Hubei University to promote cooperation and exchanges in the field of synthetic biology. At the same time, the second synthetic Biology Industry Expo 2024 was held in Nanjing, showing the latest development of the synthetic biology industry.

Shanghai Jiaotong University launched CNSB Project of carbon negative synthetic Biology the CNSB project of carbon negative synthetic Biology supported by Singapore National Foundation was launched in Shanghai Jiaotong University, which represents an important milestone in promoting the construction of Singapore branch center by National Science Center of Translational Medicine (Shanghai).

Anhui Huaheng Biotechnology Co., Ltd. recently announced that its two bio-based materials projects in Chifeng base have achieved high-quality continuous production. This marks an important step forward for Hua Heng Biology in the bio-based materials industry.

Shenzhen state-owned assets 1.5 billion invested in synthetic biological industry to promote industrial development and innovation Shenzhen synthetic biological industry private equity fund partnership was established, with an initial capital contribution of 1.5 billion yuan. The fund will focus on investment in synthetic biology and aims to promote the development and innovation of related industries.

State creators have made innovative breakthroughs in spider silk protein synthesis technology, synthetic biology cutting-edge enterprise state creators have promoted the development of bio-based materials by applying AI technology to protein structure optimization. The company has made innovative breakthroughs in spider silk protein synthesis technology, giving new impetus to the development of synthetic biomaterials (310328).

[risk Tip] when considering investments in synthetic biology, investors should pay attention to potential risks such as policy disturbances, technology diffusion, new technology breakthroughs, global intellectual property disputes, global trade disputes, and tightening carbon emissions, as well as fluctuations in raw material prices and changes in the economic situation.